EULAR: Early and intensive treatment of rheumatoid arthritis reduces fatigue

Kilchberg/Switzerland: Disease-related, profound fatigue impairs the quality of life of many people with rheumatic and musculoskeletal diseases. A Belgian study (1) has now concluded that early intensive treatment combining methotrexate with a bridging scheme of prednisone can reduce the onerous fatigue – this also applies to patients at low risk of a severe course. The…

UConn researchers overcome a vexing problem in vaccine research

Researchers at UConn’s Center of Excellence in Vaccine Research (CEVR) have made a breakthrough in vaccine development for a common and difficult to treat pneumonia-causing pathogen. Their research was recently published in the Nature Partner Journal – Vaccines. For Mycoplasma pneumoniae, vaccine development has been stalled since the 1960s due to a phenomena called vaccine-enhanced…